OBJECTIVE: Axonal excitability reflects ion channel function and it is proposed that this may be a biomarker in painful (versus painless) polyneuropathy. Our objective was to investigate the relationship between axonal excitability parameters and chronic neuropathic pain in deeply phenotyped cohorts with diabetic or chemotherapy induced distal symmetrical polyneuropathy. METHODS: 239 participants with diabetic polyneuropathy were recruited from sites in the UK and Denmark, and 39 participants that developed chemotherapy-induced polyneuropathy were recruited from Denmark. Participants were separated into those with probable or definite neuropathic pain and those without neuropathic pain. Axonal excitability of large myelinated fibres was mea...
Diabetic polyneuropathy (DPN) is a major cause of neuropathic pain and a frequent target condition i...
Although a number of the diabetic neuropathies may result in painful symptomatology, this review foc...
The usefulness of sensory symptoms in the assessment of diabetic polyneuropathy is unclear. In the p...
[[abstract]]Diabetes neuropathy is a common complication of diabetes, and neuropathic pain has a det...
[[abstract]]Diabetes neuropathy is a common complication of diabetes, and neuropathic pain has a det...
Disabling neuropathic pain (NeuP) is a common sequel of diabetic peripheral neuropathy (DPN). We aim...
Disabling neuropathic pain (NeuP) is a common sequel of diabetic peripheral neuropathy (DPN). We aim...
[[abstract]]Background: Painful diabetic neuropathy occurs in approximately 25-30% of patients with ...
Background: We aimed at evaluating the differential involvement of large myelinated Aβ-, small myeli...
[[abstract]]Background: Painful diabetic neuropathy occurs in approximately 25-30% of patients with ...
[[abstract]]Background: Painful diabetic neuropathy occurs in approximately 25-30% of patients with ...
Consistent associations between the severity of neuropathic pain and cutaneous innervation have not ...
Diabetic polyneuropathy (DPN) is a major cause of neuropathic pain and a frequent target condition i...
In patients with distal symmetric polyneuropathy we assessed non-nociceptive Aβ- and nociceptive Aδ-...
Purpose of Review: The prevalence of diabetes mellitus and its chronic complications are increasing ...
Diabetic polyneuropathy (DPN) is a major cause of neuropathic pain and a frequent target condition i...
Although a number of the diabetic neuropathies may result in painful symptomatology, this review foc...
The usefulness of sensory symptoms in the assessment of diabetic polyneuropathy is unclear. In the p...
[[abstract]]Diabetes neuropathy is a common complication of diabetes, and neuropathic pain has a det...
[[abstract]]Diabetes neuropathy is a common complication of diabetes, and neuropathic pain has a det...
Disabling neuropathic pain (NeuP) is a common sequel of diabetic peripheral neuropathy (DPN). We aim...
Disabling neuropathic pain (NeuP) is a common sequel of diabetic peripheral neuropathy (DPN). We aim...
[[abstract]]Background: Painful diabetic neuropathy occurs in approximately 25-30% of patients with ...
Background: We aimed at evaluating the differential involvement of large myelinated Aβ-, small myeli...
[[abstract]]Background: Painful diabetic neuropathy occurs in approximately 25-30% of patients with ...
[[abstract]]Background: Painful diabetic neuropathy occurs in approximately 25-30% of patients with ...
Consistent associations between the severity of neuropathic pain and cutaneous innervation have not ...
Diabetic polyneuropathy (DPN) is a major cause of neuropathic pain and a frequent target condition i...
In patients with distal symmetric polyneuropathy we assessed non-nociceptive Aβ- and nociceptive Aδ-...
Purpose of Review: The prevalence of diabetes mellitus and its chronic complications are increasing ...
Diabetic polyneuropathy (DPN) is a major cause of neuropathic pain and a frequent target condition i...
Although a number of the diabetic neuropathies may result in painful symptomatology, this review foc...
The usefulness of sensory symptoms in the assessment of diabetic polyneuropathy is unclear. In the p...